News & Events CTI Clinical Trial and Consulting Services to Present at Biotech Showcase™ 2014

CTI Clinical Trial and Consulting Services to Present at Biotech Showcase™ 2014

January 9, 2014

CTI Clinical Trial and Consulting Services (CTI) announces that Timothy J. Schroeder, Chief Executive Officer, will present at the Biotech Showcase™ 2014 Conference which will be held in San Francisco, California.  Mr. Schroeder will be presenting Monday, January 13th.

“CTI currently provides services to approximately 70 pharmaceutical, biotechnology, and medical device companies,” according to Mr. Schroeder. “Our mission is to deliver outstanding customer service, execute high quality projects on-time and on-budget, and conduct trials that benefit the lives of critically and chronically ill patients. Presenting at Biotech Showcase™ allows us the opportunity to spotlight the successes we enjoyed with our partner organizations, especially in the biotechnology field. We have optimism for the future of health care based upon the cutting edge research we actively lead.”

Mr. Schroeder founded CTI fifteen years ago, and is internationally recognized in the field of transplantation, regenerative medicine, nephrology, rare diseases, and special patient populations, including pediatrics. During his more than 30 years in clinical, academic, and industry experience, he has authored more than 200 peer reviewed publications and has presented more than 300 papers at national and international conferences. He has also served as a visiting lecturer on more than 200 occasions.

Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry’s largest annual healthcare investor conferences. Now in its sixth year, Biotech Showcase is expected to attract upwards of 1,500 attendees.  

 

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization with a focus on immunology and a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and startup firms with clinical and disease area expertise from a unique mix of academic, medical and industry specialists; rich intellectual capital in transplantation, immunology, infectious diseases, hematology,  cardiology, nephrology, hepatology, regenerative medicine and rare diseases; flexible study designs that accelerate development programs and deliver high approval ratings that are among the best in the industry; and exceptional global project management and gold standard safety and data management systems that strengthen their program’s success potential. Established in 1999 and headquartered in Cincinnati, OH; CTI has offices in North America, Europe and South America.

About Demy-Colton Life Science Advisors

Demy-Colton Life Science Advisors is focused exclusively on facilitating the growth of the life science industry. Now going into its fifth year, Demy-Colton has developed a number of high-value added conferences to address the

business and development needs of the biotechnology industry; it provides partnering services and it has helped launch a unique investor website and newsletter. For more information please visit www.demy-colton.com.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success. For more information please visit www.ebdgroup.com or follow EBD Group on Twitter at twitter.com/ebdgroup.

Subscribe to our mailing list

* indicates required